Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma

by Castella, Barbara, Foglietta, Myriam, Sciancalepore, Patrizia, Rigoni, Micol, Coscia, Marta, Griggio, Valentina, Vitale, Candida, Ferracini, Riccardo, Saraci, Elona, Omedé, Paola, Riganti, Chiara, Palumbo, Antonio, Boccadoro, Mario, Massaia, Massimo
Published 2015

Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells

by Rigoni, Micol, Riganti, Chiara, Vitale, Candida, Griggio, Valentina, Campia, Ivana, Robino, Marta, Foglietta, Myriam, Castella, Barbara, Sciancalepore, Patrizia, Buondonno, Ilaria, Drandi, Daniela, Ladetto, Marco, Boccadoro, Mario, Massaia, Massimo, Coscia, Marta
Published 2015

Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients

by Foglietta, Myriam, Neelapu, Sattva S., Kwak, Larry W., Jiang, Yunfang, Nattamai, Durga, Lee, Seung-Tae, Fowler, Daniel H., Sportes, Claude, Gress, Ronald E., Steinberg, Seth M., Vence, Luis M., Radvanyi, Laszlo, Dwyer, Karen C., Qazilbash, Muzzaffar H., Bryant, Kelly, Bishop, Michael R.
Published 2012